CPHI Online is the largest global marketplace in the pharma ingredients industry
About Medis ehf.
Medis is a leader in pharmaceutical development and out licensing, offering a broad portfolio of quality pharmaceutical products and comprehensive registration dossiers and intellectual property since 1985. Medis is a powerful partner with a proven track record in securing regulatory approval prior to patent expiries, and has obtained marketing authorizations in over 140 countries to date. We out-license products from the pipeline of our parent company, Teva. Medis ehf is 100% owned by Teva Pharmaceutical Industries Ltd (NYSE, TASE: TEVA).
•Dossiers with product supply for generic products for all major therapeutic categories
•Full launch coordination to ensure customers timely Day-1 launches to market
•High quality generic products and registration dossiers according to current EU standards (CTD)
•Extensive generic portfolio with more than 150 dossiers and around 800 available licenses
Products from Medis ehf. (1)
Medis ehf. Resources (1)
A short explainer video introducing Medis now, our online customer portal which gives our customers access to valuable information, insights and ordering capabilities 24/7.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
Generate high-quality, engaged leads for your business, all year round
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
Your company’s profile boosted at all participating CPHI events
An easy-to-use platform with a detailed dashboard showing your leads and performance